According to Biolase 's latest financial reports the company's total liabilities are $32.86 M. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2022-12-31 | $33.29 M | 10.71% |
2021-12-31 | $30.07 M | -2.97% |
2020-12-31 | $30.99 M | -1.5% |
2019-12-31 | $31.47 M | 14.74% |
2018-12-31 | $27.42 M | 99.85% |
2017-12-31 | $13.72 M | -30.95% |
2016-12-31 | $19.87 M | 14.72% |
2015-12-31 | $17.32 M | -0.12% |
2014-12-31 | $17.34 M | -23.1% |
2013-12-31 | $22.55 M | 11.78% |
2012-12-31 | $20.17 M | 17.06% |
2011-12-31 | $17.23 M | -18.67% |
2010-12-31 | $21.19 M | 48.75% |
2009-12-31 | $14.24 M | -45.86% |
2008-12-31 | $26.31 M | -5.39% |
2007-12-31 | $27.81 M | 4.53% |
2006-12-31 | $26.61 M | 11.65% |
2005-12-31 | $23.83 M | -3.77% |
2004-12-31 | $24.76 M | 84.86% |
2003-12-31 | $13.39 M | 4.01% |
2002-12-31 | $12.88 M | 115.35% |
2001-12-31 | $5.98 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Align Technology
ALGN | $2.45 B | 7,365.96% | ๐บ๐ธ USA |
Dentsply Sirona
XRAY | $4.07 B | 12,303.76% | ๐บ๐ธ USA |